Abivax CEO responds to Lilly acquisition rumors
Source: SeekingAlpha
2026-01-20 10:16:24 ET
More on Abivax, Eli Lilly
- Eli Lilly: Exceptional 2025, But Rising Headwinds Loom In 2026
- Eli Lilly: Sell It And Buy Novo Nordisk Instead
- 44th Annual J.P. Morgan Healthcare Conference
- Key deals this week: Micron Technology, Worthington Steel, Boston Scientific, CrowdStrike and more
- Eli Lilly drops as FDA decision on weight loss pill is now expected in April
Read the full article on Seeking Alpha
For further details see:
Abivax CEO responds to Lilly acquisition rumors
Abivax SA
NASDAQ: ABVX
ABVX Trading
5.79% G/L:
$122.88 Last:
583,847 Volume:
$119.99 Open:
ABVX Latest News
March 10, 2026 04:20:00 pm
Billionaire Steve Cohen Owns Shares of This Stock That Has Soared 1,600% in The Past Year
ABVX Stock Data
$9,359,969,582
53,161,297
N/A
64
N/A
Biotechnology & Life Sciences
Healthcare
FR
Paris
